Correlation between Serum PSA Level & AMACR Expression in Prostatic Cancer

Prostate cancer is the second most common cause of cancer and the sixth leading cause of cancer death among men worldwide. To diagnose prostate cancer, no specific single histological feature is sufficiently available. A positive diagnostic marker specific for prostatic adenocarcinoma may enhance the ability to detect small foci of cancer and reduce diagnostic difficulties. This study focuses on correlation between serum PSA level and AMACR (a proven biomarker) expression in prostate cancer.